Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 6399874

Invasive exercise testing.

W J Bugni
View original source ↗Export metadata ↓

Abstract

The normal hemodynamic response to dynamic supine exercise embodies the following features: progressive increase in heart rate relative to the work intensity; an increase in cardiac output of 600 ml or greater for every 100-ml increment in oxygen consumption; minimal increase in stroke volume; a progressive increase in oxygen extraction, attaining near-maximal levels during moderate exercise; and a minimal increase in left ventricular end-diastolic, pulmonary capillary wedge, pulmonary arterial, and right ventricular end-diastolic pressures. In heart disease, the major purpose of invasive exercise testing is to assess cardiac functional reserve capacity. An evaluation of the degree of encroachment on cardiac reserve by disease processes establishes hemodynamic correlates of clinical symptomatology and aids in selecting the proper therapeutic modality for each individual patient. In patients with ischemic heart disease, preliminary evidence indicates that invasive exercise testing in conjunction with angiographic findings may contribute additional substantial prognostic information.

Explore related subjects

Blood PressureCardiac CatheterizationCardiac OutputCoronary DiseaseExercise TestHeartHeart DiseasesHeart RateHumansOxygenPhysical ExertionPrognosisStroke VolumeJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W J Bugni. 1984. Invasive exercise testing.. https://pubmed.ncbi.nlm.nih.gov/6399874/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Long-term effects of reduced renal mass in humans.

The long-term risks of kidney donation have not been well defined. We carried out meta-analysis of investigations that examined the long-term effects of reduced renal mass in humans. We used multiple linear regression to combine studies and adjust for differences in the duration of follow-up, the reason for reduced renal mass, the type of controls, age and gender. We analyzed 48 studies with 3124 patients and 1703 controls. Unilateral nephrectomy caused a decrement in glomerular filtration rate (-17.1 ml/min; 95% confidence interval -20.2 to -14.0 ml/min) that tended to improve with each 10 years of follow-up (1.4 ml/min/decade; 0.3 to 2.4 ml/min/decade). Patients with single kidneys had small, progressive increases in proteinuria (76 mg/day/decade; 52 to 101 mg/day/decade), but proteinuria was negligible after nephrectomy for trauma or kidney donation. Nephrectomy did not affect the prevalence of hypertension, but there was a small increase in systolic blood pressure (2.4 mm Hg; -0.3 to 5.1 mm Hg, P > 0.05) which rose further with duration of follow-up (1.1 mm Hg/decade; 0.0 to 2.2 mm Hg/decade). Diastolic blood pressure was higher after nephrectomy (3.1 mm Hg; 1.8 to 4.4 mm Hg), but this increment did not change with duration of follow-up. Thus, in normal individuals, unilateral nephrectomy does not cause progressive renal dysfunction, but may be associated with a small increase in blood pressure.

Blood Pressure↗
PubMed1995

Adjustment of the apparent benefits of treatment on stroke risk in the MRC mild hypertension trial using data from the placebo-treated group.

Clinical trials show that drug treatment significantly decreases stroke risk in hypertension. The benefit as measured in clinical trials may be affected by changes of blood pressure at entry and by departure from randomised treatment, but the magnitude of such effects is disputed. We have assessed benefit from reduction of stroke using data from the MRC Trial of mild to moderate hypertension, taking these factors into account, and have studied the likely effect of recent guidelines. The original analysis suggested that 850 patients needed treatment for 1 year to prevent one stroke. Under the more conservative of two assumptions made about the effect of treatment, this falls to 695 patients when allowance is made for reduction of stroke in placebo group patients withdrawn and actively treated, to 680 patients when allowance is made for the fall in blood pressure after entry, and to 556 patients with allowance for both. When benefit is assessed in patients whose entry diastolic blood pressure was > or = 100 mm Hg, 557 patients require treatment annually per stroke saved and this is decreased to 360 patients when allowance is made for withdrawal and active treatment of placebo group patients. These results suggest that benefit from reduction of stroke was underestimated in the MRC trial and that this is likely to be present in most trials. Changes to diagnostic criteria for hypertension in new management guidelines are likely to have significant effects on the number of patients treated per stroke prevented.

Blood Pressure↗
PubMed1995

Ambulatory blood pressure monitoring: from research to clinical practice.

Evidence from the medical literature is reviewed to indicate that ambulatory monitoring of blood pressure (ABPM) is a better predictor of target organ damage and clinical outcome in the hypertensive patient than clinic measurements of blood pressure (BP). A re-analysis of the documented BPs from the placebo limb of the Medical Research Council's treatment trial of mild hypertension is presented to indicate the difficulties inherent in the advice given by the various published guidelines on the diagnosis and management of hypertension. Finally, it is argued that because ABPM identifies a similar proportion of patients for treatment as a more prolonged follow-up, its use should be considered in the evaluation of all patients with mild hypertension as they can be categorised rapidly with less risk of being 'lost to follow-up'.

Blood Pressure↗